Industry Insight
Information, Observation & Analysis
Autoimmune Disorders Articles
More research is needed to understand why overactive mast cells trigger allergy-like reactions in this rare condition.
While still in their early stages of research, FDA has approved more than a dozen complement inhibitors to treat various conditions, and there is hope that more will be on the horizon to treat others.